Michael A Linden Veronika Bachanova Zohar Sachs Jo-Anne H Young Timothy P Singleton Celalettin Ustun
10.3109/10428194.2012.691484
Leuk Lymphoma
2013 Jan;54(1):174-6.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/22568510/
Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Murine-Derived / immunology Drug Hypersensitivity / immunology Leukemia, Lymphocytic, Chronic, B-Cell / complications Leukemia, Lymphocytic, Chronic, B-Cell / immunology Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, Large B-Cell, Diffuse / etiology
Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Murine-Derived / immunology Drug Hypersensitivity / immunology Leukemia, Lymphocytic, Chronic, B-Cell / complications Leukemia, Lymphocytic, Chronic, B-Cell / immunology Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, Large B-Cell, Diffuse / etiology Case Reports Letter Adult Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Murine-Derived / therapeutic use Antineoplastic Agents / therapeutic use Bone Marrow / pathology Female Hematopoietic Stem Cell Transplantation Humans Leukemia, Lymphocytic, Chronic, B-Cell / pathology Leukemia, Lymphocytic, Chronic, B-Cell / therapy Lymphoma, Large B-Cell, Diffuse / pathology Rituximab Transplantation, Homologous Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Rituximab ofatumumab
PMC4343282
22568510
Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab
2013